IL17A and ankylosis: An important future priority will be to determine whether this agent might prevent the development of ankylosis, which would support the dual inhibition hypothesis and be consistent with the in-vitro data that blockade of both IL-17A and IL-17F is more effective at preventing osteogenic differentiation of periosteal stem cells than blockade of either cytokine alone.